UC San Diego Health
La Jolla, California, 92037, United States
NCT Number: NCT06964152
The purpose of this study is to evaluate the clinical outcomes (clinical efficacy and safety) of using supplemental non-invasive computational ECG and cardiac imaging analysis tools to help guide ablation of ventricular tachycardia.
Interested in participating?
Request Info21 year–90 year
All sexes
Interventional
Not applicable
La Jolla, California, 92037, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of non-invasive computational ECG and cardiac CT models to localize arrhythmia origins
Time frame: 1 year
Ventricular tachycardia episodes defined as implantable cardioverter defibrillator (ICD) therapies (anti-tachycardia pacing and shocks)
Time frame: 1 year
Time frame: 24 hours post-op
acute development of hypotension, cardiogenic shock, escalation of inotropes/pressors, or need for unplanned percutaneous hemodynamic support
Time frame: 48 hours
In outpatient elective cases, change in patient condiction neccessitating unplanned ICU upgrade lasting longer than 48 hours.
Time frame: 24 hours post-op
Time frame: 24 hours post-op
new expanding hemorrhagic pericardial effusion causing tamponade requiring urgent pericardiocentesis
Time frame: 24 hours post-op
vascular access complication (bleeding or occlusion) requiring blood transfusion or vascular procedure (such as peripheral angioplasty)
University of California, San Diego
Other
Prospective Use of Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)
Acronym: AI-VT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07688200
Arrhythmias, Cardiac, Arrhythmogenic Cardiomyopathy (AC, ARVD/C)
View Trial DetailsNCT06745778
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Wenzhou, Zhejiang, China
View Trial DetailsNCT07348991
Arrhythmia, Sinus, Arrhythmias, Cardiac
View Trial DetailsNCT05158751
Arrhythmias, Cardiac, Cardiac Complexes, Premature
Overland Park, Kansas, United States
View Trial Details